The Director will provide strategic leadership for the Field Medical function across the Western USA, engaging with healthcare professionals and key opinion leaders to support the company's cell therapy and autoimmune portfolio. They will also oversee regional scientific activities, mentor the MSL team, and ensure cross-functional alignment with clinical, regulatory, and commercial departments.
The Sr. Medical Director will serve as the senior physician for CAR T-cell therapy clinical trials, overseeing study design, medical monitoring, and data interpretation. They will partner cross-functionally to lead clinical development strategies, regulatory submissions, and external engagement with investigators and key thought leaders.
Lead the medical and scientific direction of CAR T-cell clinical trials for autoimmune diseases, including trial design, execution, monitoring, and interpretation of safety, efficacy, pharmacokinetic, and biomarker data. Develop clinical and regulatory documents, collaborate with internal and external teams, and support investigator-sponsored studies and research partnerships.
The Safety Writer/Scientist will draft critical regulatory safety documents, including responses to FDA Information Requests and signal assessment reports. They will also collaborate with cross-functional teams to ensure scientific accuracy and regulatory alignment across safety-related materials.
The Senior Director will lead the design, execution, and interpretation of CAR T-cell therapy clinical trials for autoimmune diseases. They will also partner with cross-functional teams to manage regulatory submissions, clinical strategy, and the development of high-performing clinical staff.
The role involves managing the end-to-end Medical, Legal, and Regulatory (MLR) review process for promotional materials and coordinating commercial meetings and events. You will partner with cross-functional teams to ensure compliance, operational efficiency, and effective asset management using Veeva PromoMats.
The specialist will drive commercial strategy and demand for cell therapies within assigned accounts by building relationships with key stakeholders and referral networks. They will act as a commercial quarterback, coordinating internal cross-functional teams to address barriers in the patient journey and ensure treatment center readiness.
The specialist will serve as the commercial account lead for designated treatment centers and referral networks to drive demand and support the launch of cell therapies. They are responsible for developing strategic account plans, mapping patient referral pathways, and coordinating internal cross-functional teams to address barriers in the patient journey.
The specialist will serve as the commercial account lead for designated treatment centers and referral networks to drive demand and adoption of cell therapies. They are responsible for executing strategic account plans, mapping patient referral pathways, and coordinating internal cross-functional teams to address barriers in the patient journey.
The specialist will drive commercial strategy and demand for cell therapies by managing relationships with treatment centers and referral networks. They will act as a commercial quarterback, coordinating internal cross-functional teams to address patient journey barriers and ensure operational readiness.
The MSL will serve as a field-based scientific expert, engaging with healthcare professionals and key opinion leaders to communicate clinical data and support CAR-T therapy programs. They are responsible for developing territory-specific engagement plans and collaborating with internal teams to support clinical trial feasibility and medical strategy.
The Medical Science Liaison will serve as a field-based scientific expert, engaging with healthcare professionals and key opinion leaders to communicate clinical data and support CAR-T therapy programs. They will also collaborate with internal teams to support clinical trials, gather medical insights, and execute territory-specific engagement strategies.
The MSL will serve as a field-based scientific expert, managing relationships with key opinion leaders and healthcare professionals to support Kyverna’s CAR-T therapy programs. They will also collaborate with clinical teams to support trial awareness, site identification, and the communication of complex clinical data.
The MSL will serve as a field-based scientific expert, managing relationships with key opinion leaders and investigators to support Kyverna's CAR-T therapy programs. They will also contribute to clinical trial feasibility, gather medical insights, and ensure compliant scientific exchange within their assigned territory.
The Accounts Payable Specialist will manage the full invoice lifecycle, including vendor onboarding, invoice processing, and discrepancy resolution within the Coupa platform. They will also support month-end close activities, reconcile accounts, and ensure compliance with tax regulations and company policies.
The Director of Training will design and lead a comprehensive global training strategy for Medical and Commercial field teams focused on cell therapy assets. This role involves building scalable onboarding, certification, and continuous learning programs while ensuring compliance with regulatory standards.
The Senior Manager will independently author and finalize complex regulatory documents to support clinical development programs and FDA interactions. They will collaborate with cross-functional teams to ensure scientific accuracy and compliance with regulatory standards.
The Executive Director, Lifecycle Lead is responsible for driving integrated asset strategies across the full product lifecycle, from early research through commercial launch. This role coordinates cross-functional teams to ensure alignment in clinical development, manufacturing, regulatory, and commercial objectives.
Lead the company's technology strategy and transition from a development-stage biotech to a commercial organization. Oversee enterprise applications, cybersecurity, infrastructure, and GxP validation while partnering with cross-functional business leaders.
Lead global regulatory strategy for cell therapy programs from early development through commercial launch and post-approval lifecycle management. Serve as the primary interface with health authorities like the FDA and EMA to negotiate labeling and ensure regulatory compliance.
